Press release
Lipid Nanoparticles Revolutionizing Chronic Disease Management Amid Rising Prevalence: The Driving Engine Behind Lipid Nanoparticles Market Evolution in 2025
Lipid Nanoparticles Market
Lipid Nanoparticles Market Size Growth Forecast: What to Expect by 2025?
The market size of lipid nanoparticles has witnessed a swift acceleration in the past few years. The projected growth is from $1.04 billion in 2024 to $1.22 billion in 2025, representing a compound annual growth rate (CAGR) of 17.3%. The historic period's enhancement can be credited to the rising emphasis on creating drugs based on LNP, a robust investment in research infrastructure, and an overall growth in healthcare spending.
How Will the Lipid Nanoparticles Market Size Evolve and Grow by 2029?
Expectations are high for the lipid nanoparticles market over the coming years, with projections showing a surge to $2.27 billion by 2029. This represents a compound annual growth rate (CAGR) of 16.9%. The anticipated growth during this period is linked to several key factors. These include an increased prevalence of chronic illnesses, heightened demand for RNA-based therapeutics, a surge in the need for advanced gene delivery systems, an intensified focus on personalized medicine, and growth in investment towards research and development. Furthermore, the forecasted period will likely see advancements in drug delivery technologies, the introduction of innovative drug delivery systems, and the incorporation of artificial intelligence into LNP development.
View the full report here:
https://www.thebusinessresearchcompany.com/report/lipid-nanoparticles-global-market-report
What Drivers Are Propelling the Growth of Lipid Nanoparticles Market Forward?
The escalating incidence of chronic illnesses is catalyzing the expansion of the lipid nanoparticles (LNPs) market. Chronic conditions, which last typically for more than three months and encompass diseases like diabetes and hypertension, are on the rise due to factors such as unhealthy lifestyle choices, aging populations, tobacco usage, poor nutrition, lack of physical activity, and excessive drinking. Lipid nanoparticles (LNPs), with their ability to increase the efficacy of mRNA therapeutics and vaccines, present an efficient solution for chronic disease management. They enhance the treatment scenario for multiple chronic illnesses, thus providing potential for more effective management strategies and improved patient outcomes. As an example, in 2024, the National Health Service, a government department in the UK, identified over half a million extra individuals (549,000) in England at high risk of developing type 2 diabetes in 2023, raising the total number of non-diabetic hyperglycemia or prediabetes patients registered with a GP to 3,615,330. compared to 3,065,825 in 2022, this marks a significant increase of almost 20%. Thus, the escalating incidence of chronic illnesses is propelling the development of the lipid nanoparticle market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15210&type=smp
Which Emerging Trends Are Transforming the Lipid Nanoparticles Market in 2025?
Big players in the lipid nanoparticles (LNPs) market are pushing the boundaries in innovation by introducing circular RNA (circRNA) and lipid nanoparticle (LNP) formulations, in an effort to stay at the forefront of the industry. This expansion into circRNA and LNP formulation increases the spectrum of RNA formats available, incorporating circRNA, which is a single-stranded RNA that forms a covalently closed loop. Notably, in September 2023, GenScript Biotech, a life sciences company based in the US, broadened its reagent services portfolio to incorporate circRNA and LNP formulation. These additional services, immediately available as part of GenScript's contract-manufacturing reagent offerings, underscore the company's dedication to advancing protein replacement therapies and gene and cell therapy. Furthermore, circRNA has several superior characteristics compared to traditional linear RNA, such as enhanced stability, slower degradation rate, and ability to produce the required therapeutic protein levels at lower doses.
What Are the Key Segments in the Lipid Nanoparticles Market?
The lipid nanoparticles market covered in this report is segmented -
1) By Type: Nano-Structured Lipid Carriers (NLCs), Solid Lipid Nanoparticles (SLNs), Other Types
2) By Application: Research, Therapeutics
3) By End User: Pharmaceutical And Biotechnology Companies, Academics And Research Centers, Other End Users
Subsegments:
1) By Nano-Structured Lipid Carriers (NLCs): Hard NLCs, Soft NLCs
2) By Solid Lipid Nanoparticles (SLNs): Conventional SLNs, Modified SLNs
3) By Other Types: Lipid-Core Micelles, Liposomes
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15210&type=smp
Who Are the Key Players Shaping the Lipid Nanoparticles Market's Competitive Landscape?
Major companies operating in the lipid nanoparticles (LNPs) market report are Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bayer AG; Abbott Laboratories; Amgen Inc; The Merck Group; Evonik Industries AG; BioNTech SE; Moderna Inc.; Sanofi SA; Solid Biosciences Inc.; AstraZeneca PLC; NOF Corporation; Alnylam Pharmaceuticals Inc.; Nanomerics Ltd.; CordenPharma International; Nippon Fine Chemical; Helix Biotech Inc.; Dicerna Pharmaceuticals; Gattefossé SAS; Arbutus Biopharma; Avanti Polar Lipids; IOI Oleo GmbH; Evox Therapeutics Ltd.
What Geographic Markets Are Powering Growth in the Lipid Nanoparticles Market?
North America was the largest region in the lipid nanoparticles (LNPs) market in 2024. The regions covered in the lipid nanoparticles (LNPs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15210
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lipid Nanoparticles Revolutionizing Chronic Disease Management Amid Rising Prevalence: The Driving Engine Behind Lipid Nanoparticles Market Evolution in 2025 here
News-ID: 4123773 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Lipid
Key Trends Shaping the Future Lipid Market From 2025-2034: Advancements In Scala …
What industry-specific factors are fueling the growth of the lipid market?
The lipid market's expansion is projected to be fuelled by a growing demand for nutritional supplements. The increase in nutritional requirements resulting from a more active lifestyle or health condition is often met with supplementation. Lipid-based nutrient supplements - those where lipids supply the majority of the energy and also encompass protein, energy, essential fatty acids, and micronutrients - play…
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the…
Lipid Regulators Market Report 2024 - Lipid Regulators Market Trends And Growth
"The Business Research Company recently released a comprehensive report on the Global Lipid Regulators Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Lipid Research: Creative Biolabs Launches Its Lipid-Based Delivery Solutions
Creative Biolabs, a leading biotechnology company, unveiled its latest solutions for developing lipid-based delivery systems last week.
New York, USA - April 18, 2024 - "Liposomes as excellent drug delivery vehicles continuously drive innovation in drug delivery development and open up new breakthroughs and possibilities. Building on this momentum, we have designed a suite of solutions for lipid-based delivery system development," said an expert from the Lipid Research Department, Creative Biolabs.
Image:…
Creative Biolabs: Unlocking Lipid Biology With Complete Lipid Analysis Solutions
Creative Biolabs, a pioneer in the field of biotechnology, is delighted to announce the launch of cutting-edge assay and analysis solutions tailored specifically for liposome drug delivery.
New York, USA - March 26, 2024 - Liposomes, versatile lipid-based structures, have emerged as promising carriers for drug delivery due to their biocompatibility, flexibility, and capacity to encapsulate a wide range of therapeutics. To ensure the successful development of lipid-based drug delivery systems,…
Lipid Nanoparticles (LNP) Market Growth Is Attributed To The Increasing Demand F …
According to Precision Business Insights (PBI) latest report, the Lipid Nanoparticles (LNP) Market size is expected to be worth USD 675.0 Million in 2022, growing at a 7.5% CAGR from 2022 to 2028. The growing demand for therapeutic drugs and vaccinations to combat viral illnesses like Ebola, influenza, HIV, and other viruses, together with the traditional vaccine approach's failure to find vaccines in time for a crisis, are all contributing…
